- Frequency and impact of grade three or four toxicities of novel agents on outcomes of older patients with chronic lymphocytic leukemia and non-Hodgkin lymphoma (alliance A151611). Journal of Geriatric Oncology. 2018 Academic Article GET IT
- The preference to receive chemotherapy and cancer-related outcomes in older adults with breast cancer CALGB 49907 (alliance). Journal of Geriatric Oncology. 2018 Academic Article GET IT
Using ePrognosis to estimate 2-year all-cause mortality in older women with breast cancer: Cancer and Leukemia Group B (CALGB) 49907 and 369901 (Alliance A151503).
Breast Cancer Research and Treatment.
Times cited: 2
Soluble epidermal growth factor receptor (sEGFR/sErbB1) as a potential risk, screening, and diagnostic serum biomarker of epithelial ovarian cancer.
Cancer Epidemiology Biomarkers and Prevention.
Times cited: 77
EGF receptor/ErbB isoforms as serum biomarkers in breast and ovarian cancer.
Journal of Clinical Ligand Assay.
Times cited: 3